Yahoo
OTC Markets OTCID USD

Lotus Pharmaceuticals, Inc. (LTUS)

0.0031 0.0000 (0.00%)
At close: November 6 at 4:00:00 PM EST
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements have been upgraded
A new layout with more detail in every statement.
TTM
Total Revenue
71,391.0020
Cost of Revenue
-45,943.5230
Gross Profit
25,447.4790
Selling, General and Administrative Expenses
-15,327.3530
Research and Development Expenses
-1,954.5630
Operating Income/Expenses
-17,281.9160
Total Operating Profit/Loss
8,165.5630
Total Net Finance Income/Expense
-245.7200
Irregular Income/Expenses
-6,433.8830
Non-Operating Income/Expenses, Total
-6,679.6030
Pretax Income
1,485.9600
Provision for Income Tax
250.0730
Net Income from Continuing Operations
1,736.0330
Other Net of Taxes Adjustments
127.8330
Net Income after Non-Controlling/Minority Interests
1,736.0330
Net Income Available to Common Stockholders
1,736.0330
Diluted Net Income Available to Common Stockholders
1,736.0330
Basic EPS
-0.23
Diluted EPS
-0.21
Basic Weighted Average Shares Outstanding
53,611.6590
Diluted Weighted Average Shares Outstanding
54,827.4020
Income Statement, Supplemental
EBIT
1,731.6800
EBITDA
3,871.1650
Normalized EBITDA
11,798.0420
Normalized Income
6,492.1592
Total Unusual Items
7,926.8770
Total Unusual Items Excluding Goodwill
7,926.8770
Tax Effect of Unusual Items
3,170.7508
Tax Rate, Calculated
0.40
-

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: